E- and P-selectin Are Not Required for the Development of Experimental Autoimmune Encephalomyelitis in C57BL/6 and SJL Mice
Overview
Affiliations
In multiple sclerosis and in its animal model experimental autoimmune encephalomyelitis (EAE), inflammatory cells migrate across the endothelial blood-brain barrier (BBB) and gain access to the CNS. It is well-established that alpha4 integrins are actively involved in leukocyte recruitment across the BBB during EAE. In contrast, the role of endothelial E- and P-selectin in this process has been a controversial issue. In this study, we demonstrate that P-selectin protein can be detected in meningeal blood vessel endothelial cells in healthy SJL and C57BL/6 mice and on rare parenchymal CNS blood vessels in C57BL/6, but not SJL, mice. During EAE, expression of P-selectin but not E-selectin was found up-regulated on inflamed CNS microvessels surrounded by inflammatory infiltrates irrespective of their meningeal or parenchymal localization with a more prominent immunostaining detected in C57BL/6 as compared with SJL mice. P-selectin immunostaining could be localized to CNS endothelial cells and to CD41-positive platelets adhering to the vessel wall. Despite the presence of P-selectin in wild-type mice, E/P-selectin-deficient SJL and C57BL/6 mice developed clinical EAE indistinguishable from wild-type mice. Absence of E- and P-selectin did neither influence the activation of myelin-specific T cells nor the composition of the cellular infiltrates in the CNS during EAE. Finally, endothelial-specific tetracycline-inducible expression of E-selectin at the BBB in transgenic C57BL/6 mice did not alter the development of EAE. Thus, E- and P-selectin are not required for leukocyte recruitment across the BBB and the development of EAE in C57BL/6 and in SJL mice.
Dziedzic A, Maciak K, Miller E, Starosta M, Saluk J Int J Mol Sci. 2024; 25(7).
PMID: 38612668 PMC: 11011409. DOI: 10.3390/ijms25073858.
Mapunda J, Pareja J, Vladymyrov M, Bouillet E, Helie P, Pleskac P Nat Commun. 2023; 14(1):5837.
PMID: 37730744 PMC: 10511632. DOI: 10.1038/s41467-023-41580-4.
Lazarevic I, Soldati S, Mapunda J, Rudolph H, Rosito M, de Oliveira A Fluids Barriers CNS. 2023; 20(1):39.
PMID: 37264368 PMC: 10236715. DOI: 10.1186/s12987-023-00441-4.
The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis.
Angelini G, Bani A, Constantin G, Rossi B Front Cell Neurosci. 2023; 17:1101379.
PMID: 36874213 PMC: 9975172. DOI: 10.3389/fncel.2023.1101379.
Thinking outside the box: non-canonical targets in multiple sclerosis.
Bierhansl L, Hartung H, Aktas O, Ruck T, Roden M, Meuth S Nat Rev Drug Discov. 2022; 21(8):578-600.
PMID: 35668103 PMC: 9169033. DOI: 10.1038/s41573-022-00477-5.